Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

NCT00003634 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Fallopian Tube Cancer
Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

BIOLOGICAL: oregovomab

Sponsor

AltaRex